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Introduction
Community-acquired pneumonia (CAP) is a
highly prevalent infectious disease with worldwide
distribution. The annual rate of incidence in adults
varies between 1.62 and 13.4 per 1,000 inhabi-
tants, and hospitalization rate ranges between 22%
and 51%1. The decision to treat the patient as an
outpatient or inpatient is of primary importance for
the management and final cost2. In addition to
clinical judgement, the attending physician may
use certain scales as predictors of mortality such as
CURB-653 or the Pneumonia Severity Index (PSI)4,5
to identify patients with CAP as candidates for out-
patient treatment6-9.
If outpatient treatment is excluded, the physi-
cian must decide on where best to refer such pa-
tients: short stay units (SSU), conventional hospital-
ization (CH) or intensive medicine units (IMU)9. In
the past 20 years, many Spanish hospitals have es-
tablished SSU. The main candidates for admission
to these units are patients with previously diag-
nosed chronic disease and current decompensa-
tion, and patients with acute disease and high
probability of CAP diagnosed in the emergency de-
partment (ED) and expected to respond favorably
to treatment within 48-72 hours and where the
need for intensive care is not expected10-15.
Regarding the choice of destination for treating
CAP in a hospital unit, there are recommendations
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based on risk scores. According to these recom-
mendations, patients with PSI risk scores I and II
should be treated as outpatients (in the absence of
other causes, related with CAP or not, justifying
hospital admission). PSI III patients should be treat-
ed in observation units or SSU. And PSI IV and V
patients should be referred to CH or IMU9.
Given that the incidence of CAP is higher in the
elderly than in young adults1, implementing these
PSI-based recommendations where age weighs
heavily on final score, a large number of elderly pa-
tients meet the criteria for hospital admission,
mostly CH16,17. Since prolonged hospital stay can
contribute to increased complications it seems ne-
cessary to consider SSU as a suitable destination for
the treatment of CAP in selected patients without a
priori excluding any risk group.
The objective of this study is to describe our ex-
perience in treating patients diagnosed with CAP
and admitted to a SSU, and assess whether safety
measured by readmission rates and mortality is
similar to patients with CAP treated in CH.
Method
The study was conducted at the University Hos-
pital Bellvitge (HUB), a third-level hospital for
adults with approximately 860 beds. This is the re-
ferral hospital for a population of 1.5 million in-
habitants. The ED has approximately 120,000 visits
per year (no pediatric or obstetric patients). The
SSU was initiated in 1997; it has 24 beds, its own
staff 24 hours a day and depends directly on the
ED. The decision on SSU admission is taken by
consensus between the attending ED physician and
the physician responsible for the SSU. After 72
hours, in cases of favorable evolution, patients may
be discharged home, receive home hospitalization,
or transferred to a sub-acute center. Otherwise,
they are admitted to a CH or IMU.
The study period was from November 2005 to
April 2007; it included all consecutive cases of HUB
patients with a discharge diagnosis of CAP. Diag-
nostic criteria as recommended in the literature
were followed: symptoms compatible with CAP,
acute onset of symptoms and the appearance of a
new infiltrate on chest X-ray9. Patients diagnosed
with aspiration pneumonia, lung cancer and others
requiring ICU admission during their stay were ex-
cluded. Patients with HIV infection, immunosup-
pression, hemodialysis or those currently institu-
tionalized were not excluded from the study.
Enrolled patients were divided into two groups:
group 1 comprised those admitted to the SSU, and
group 2 (or control group) were those admitted to
a CH (internal medicine, pulmonology and infec-
tious diseases unit).
The exclusion criteria for SSU admission of pa-
tients with suspected CAP are: a) uncertain diagno-
sis, b) those receiving intensive treatment, c) sus-
pected nosocomial pneumonia and d) social
problems that do not allow early discharge. Age,
institutionalization, or immunosuppression or
chronic comorbidity are not considered criteria for
exclusion.
The study data, entered on a specific data-base,
included: a) demographics (age and sex), b) prior
health status (comorbidity using the Charlson in-
dex), c) objective severity rating at admission
(CURB 65 -confusion, uremia, respiratory rate,
blood pressure age, ≥65 years, and PSI score), d)
episode complexity (mean weight of diagnosis re-
lated groups DRG), e) laboratory microbiological
determinations from samples collected in the ED or
during admission episode (blood, gram and spu-
tum culture, serology for Streptococcus pneumoniae
and Legionella pneumophila serogroup 1 and serolo-
gy for Chlamydia pneumoniae, Legionella pneu-
mophila, Coxiella burnetii and Mycoplasma pneumo-
niae), f) measures of effectiveness (duration of stay,
proportion of patients discharged home versus oth-
er hospital units), and g) safety variables (mortality
rate, need to revisit the ED and hospital readmis-
sion at 10 and 30 days).
Statistical analysis was performed using SPSS for
Windows version 15.0. The descriptive analysis of
the data appears as mean (SD) or absolute number
of cases and percentages (with 95% confidence in-
terval). Differences between qualitative variables
were analyzed using chi square test. To study the
differences between groups of patients, analysis of
variance was used in the case of parametric vari-
ables and for non-parametric variables, Mann-Whit-
ney or Kruskal-Wallis test were used (depending on
the number of groups). Differences with a p
value < 0.05 were considered statistically significant.
Results
A total of 606 patients were included: 187 in
Group 1 (SSU) and 419 in Group 2 (CH). Mean
age was significantly higher in Group 1
(77.3 ± 12.04 versus 67.9 ± 15.18 years,
p < 0.0001). Comorbidity rate measured by Charl-
son index showed no differences between groups.
Average GRD weight of episodes showed greater
complexity in Group 2 (CH). Mean stay was signifi-
cantly lower in Group 1 (3.48 ± 1.70 versus
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7.89 ± 6.12 days, p < 0.0001). We observed signif-
icant differences in discharge home (80.2% in
Group 1 versus 93.2% in Group 2, p < 0.0001).
Considering discharge home together with other
alternatives to hospitalization (96.2% in Group 1
and 97.5% in Group 2), these differences disap-
peared. Only 2 patients (1.1%) in Group 1 re-
quired transfer to CH, and none to IMU (Table 1).
It is noteworthy that most of the younger pa-
tients in PSI risk groups III and IV were admitted to
hospital (Figure 1). Regarding age cutoffs, of spe-
cial interest was the limit of 60 + years (elderly)
and older than 90 + years (extremely elderly). Of
patients under 60 years (116 in total) with PSI III
and IV (44 in total), 43 (97.7%) were in Group 2
(CH) and only 1 (2.3%) in Group 1 (SSU). No pa-
tient under 60 years had the maximum PSI V in
the sample. In contrast, of the 35 patients with
90 + years, 26 (74.28%) were inGroup 1, and of
these, 21 (60%) had PSI IV.
With regard to microbiological findings (Table
2), fewer samples and determinations of sputum,
urine antigen, blood cultures and serological tests
were performed in the SSU group, and the total
number of patients with microbiological diagnosis
of the agent responsible for CAP was 60 (31.7%) in
the SSU group and 246 (58.7%) in the CH group.
For all levels of PSI, mean age of the patients
was higher in the SSU group (Table 3), especially in
groups with poor prognosis (III, IV and V). There
were no significant differences in Charlson comor-
bidity index between the groups. However, average
weight of the DRG per episode was higher in the
CH group, especially in the group of patients with
PSI V, although the number of SSU patients with
PSI V was very low (4, 2.1%) compared with the
CH group (37, 8.8%). For all risk groups, mean
stay was shorter in the SSU group than in the CH
group.
The results of the sub-analysis of patients with
Fine IV in both groups (we excluded from the
analysis those patients with Fine V due to the low
number of cases in the SSU group) are shown in
Table 5. Despite large differences in mean stay time
between the groups, no differences were found in
10 and 30-day readmission. Differences did exist in
discharge destination, especially in the use of alter-
natives to CH. Fine IV patients grouped according
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Table 1. General data and comparison of short-stay unit (SSU) versus conventional hospital unit (CH) patients
SSU (group 1, N = 187) CH (group 2, N = 419) p value
Age (years) (mean ± SD) 77.30 ± 12.04 67.93 ± 15.18 0.000
Gender [n (%)] ns
Men 113 (60.4) 277 (66.1)
Women 74 (39.6) 142 (33.9)
Provenance [n (%)] < 0.05
Home 173 (92.5) 405 (96.7)
Old-age Home 14 (7.5) 14 (3.3)
Diabetes mellitus [n (%)] 40 (21.4) 93 (22.2) ns
COPD [n (%)] 91 (48.7) 152 (36.3) < 0.01
Fine Index [n (%)] < 0.001
I 8 (4.3) 31 (7.4)
II 15 (8.0) 67 (16.0)
III 80 (42.8) 109 (26.0)
IV 80 (42.8) 175 (41.8)
V 4 (2.1) 37 (8.8)
CURB 65 index [n (%)] ns
0 22 (11.8) 74 (17.7)
1 67 (35.8) 158 (37.7)
2 73 (39.0) 140 (33.4)
3 23 (12.3) 42 (10.0)
4 2 (1.1) 4 (1.0)
5 0 (0) 1 (0.2)
Average stay (days) (mean ± SD) 3.48 ± 1.70 7.89 ± 6.12 < 0.001
Average Charlson Index (mean ± SD) 1.17 ± 1.43 1.09 ± 1.34 ns
DRG average weight (mean ± SD) 0.97 ± 0.21 1.11 ± 0.65 < 0.001
Destination at discharge [n (%)] < 0.001
Home 150 (80.2) 390 (93.1)
Home care 11 (5.9) 17 (4.1)
Another hospital 2 (1.1) 0 (0)
Sub-acute Unit 18 (9.6) 1 (0.2)
Deceased 5 (2.7) 11 (2.6)
ED readmission within 10 days [n (%)] 8 (5.0) 18 (4.4) ns
Hospital readmission within 10 days [n (%)] 5 (3.1) 10 (2.5) ns
ED readmission within 30 days [n (%)] 10 (6.2) 40 (9.8) ns
Hospital readmission within 30 days [n (%)] 6 (3.7) 23 (5.6) ns
SD: standard deviation; ED: emergency department; COPD: chronic obstructive pulmonary disease, ns: not significant; DRG: Diagnosis Related Groups.
to age still showed significantly lower length of stay
in SSU patients, with no differences in readmissions
(Table 4).
Discussion
Early discharge of selected SSU patients with
CAP showed similar safety results to CH patients
with longer times to discharge, which indicates
that the SSU can be an effective and safe alterna-
tive to CH. These results were obtained in patients
with low levels of severity (PSI I and II), intermedi-
ate (III) and PSI IV. Due to the low number of pa-
tients with PSI V in the SSU group, no comparison
was performed.
The reasons for the significantly lower mean
stay times in the SSU group are multifold. First,
clear objectives must be established from the time
of admission and any reason for possible delayed
discharge, once clinical improvement or stabiliza-
tion has been achieved, must be eliminated, to al-
low outpatient treatment. A study by Halm et al.,
published in 199818, indicated that the mean time
required for stabilization of CAP patients was three
days for most of the parameters considered (sys-
tolic blood pressure, heart rate, respiratory rate,
temperature, oxygen saturation, oral intake and
mental state). Nevertheless, 83% remained in the
hospital at least one day after stabilization. In the
study by Moeller19, 61.3% of CAP patients re-
mained in the hospital after stabilization. In another
study by Fine et al.20, physicians responsible for the
decision on hospital discharge of patients with CAP
A. Juan et al.
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Table 2. Microbiological findings (expressed in absolute numbers and percentages of the total number of determinations in each
group)
Sputum culture Urinary antigens Blood cultures Serology during stay
N (%) N (%) N (%) N (%)
SSU (N = 55) CH (N = 158) SSU (N = 119) CH (N = 382) SSU (N = 121) CH (N = 363) SSU (N = 1) CH (N = 146)
Negative 26 (47.2) 74 (46.8) 63 (52.9) 176 (46.0) 111 (91.7) 308 (84.6) 1 (100) 133 (91.7)
Streptococcus pneumoniae 14 (25.4) 49 (31.0) 54 (45.3) 183 (47.9) 8 (6.6) 44 (12.0)
Legionella pneumophila 2 (1.6) 23 (6.0) 4 (2.7)
Branhamella catharralis 7 (4.4)
Haemophilus influenzae 10 (18.1) 17 (10.7) 8 (2.1)
Pseudomona aeruginosa 2 (3.6) 4 (2.5) 1 (0.8) 1 (0.2)
Mycoplasma pneumoniae 1 (0.6)
Chlamydia psitacci 7 (4.8)
Coxiella burnetti 1 (0.6)
Other 3 (5.4) 7 (4.4) 1 (0.8) 2 (0.5)
SSU: short-stay unit; CH: conventional hospital units.
Figure 1. Distribution by age group and Fine index. CH: conventional hospital unit. SSU: short-stay
unit.
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were asked to identify the factors underlying pro-
longing patient stay beyond stability. Only 22% be-
lieved that they had prolonged the patient stay
time beyond what was necessary. The main reason
(56% of cases) was the need to evaluate or treat
other concurrent diseases.
Second, it is necessary to fine tune the duration
of intravenous antibiotic therapy and continue with
oral treatment as soon as possible. Once this
change has been implemented, clinically stable pa-
tients should be discharged21. Siegel et al. found no
differences in patient outcomes between those
treated with intravenous then oral antibiotics versus
those solely treated intravenously22. Moreover,
Rhew et al. also showed no difference in results of
hospitalized patients treated intravenously whether
or not they were placed under observation after
initiating oral treatment. These authors argue that
eliminating this practice could reduce mean stay by
at least one day23.
Third, rapid mobilization of the patient facili-
tates early discharge. In the SSU, the entire staff are
very aware of the need for early mobilization of pa-
tients as much as clinical condition permits every
day. Mundy et al., in a prospective study, showed
that CAP patients mobilized early at least 20 min-
utes during the first 24 hours of hospitalization, fol-
lowed by daily mobilization, reduced mean length
of stay without increasing the risk of adverse out-
comes24.
Fourth, it is important to avoid the adverse ef-
fects of prolonged hospitalization: early removal of
urinary catheters, careful management of intra-
venous catheters, avoidance of aggressive treat-
ments that may exacerbate chronic diseases or
cause delirium, etc.16,25.
Finally, other factors such as early social or so-
cio-sanitary measures, better coordination with oth-
er alternatives to conventional hospitalization (sub-
acute units, home hospitalization) can also help
reduce mean stay in the SSU.
In our study, the mean age of SSU patients
was higher than those admitted to CH, especially
of those with PSI III and IV. On analyzing both
groups by age decades, we found that younger
patients with higher PSI score were more likely to
be CH patients, while older patients with lower
PSI score were admitted to the SSU. This was
logical, because rapid improvement in the more
severe cases on admission could not be expected
and early discharge was improbable, while those
with better clinical condition on admission could
be expected to have shorter stay time. The elder-
ly especially benefit from shorter stay since it
helps avoid the complications associated with
prolonged hospitalization (confusion, delirium,
functional impairment, iatrogenic events, nosoco-
mial infections, pressure sores, etc.). This may ex-
plain why ED physicians tend to refer elderly pa-
tients to the SSU. There are reports on reduced
CH stay in patients older than 65 years, with re-
sults similar to those of SSU. Capelastegui et al.
in a two-year prospective study of 1,886 patients
showed that reducing stay time in patients over
65 years from 5.6 to 3.7 days did not compro-
mise safety or medical outcome26. Novak et al., in
an 18-month study performed in a unit similar to
ours, reported that CAP patients with a mean age
of 73 years admitted to their SSU had a mean
stay time of 4.3 days. Of these, 60% had a PSI of
IV, and mean stay was 4.1 days for this
subgroup27.
The proportion of microbiological diagnoses in
the CH group was almost double that of the SSU
group, with a higher number of microbiological
determinations. There seems to be no justification
for these differences, since diagnostic protocols are
the same for all patients with suspected CAP in our
hospital ED. So this is a clear area for improvement
in the management of CAP in our SSU. Of all the
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Table 3. Statistical analysis of data from different subgroups
according to Pneumonia Severity Index (PSI) for age, stay time,
Charlson index, diagnosis related group (DRG) and mortality
SSU CH p value
Age (years) (mean ± SD)
Fine I 46.0 ± 13.02 39.06 ± 11.48 < 0.01
Fine II 62.0 ± 9.66 60.06 ± 11.39 ns
Fine III 76.85 ± 7.68 66.46 ± 12.62 < 0.001
Fine IV 83.28 ± 8.03 74.35 ± 11.08 < 0.001
Fine V 86.75 ± 6.85 80.38 ± 7.59 < 0.001
Average length of stay (days) (mean ± SD)
Fine I 2.88 ± 1.81 5.52 ± 2.34 < 0.001
Fine II 2.67 ± 0.72 7.00 ± 4.48 < 0.001
Fine III 3.39 ± 1.67 6.89 ± 3.35 < 0.001
Fine IV 3.78 ± 1.77 9.09 ± 8.14 < 0.001
Fine V 3.50 ± 2.52 8.76 ± 4.73 < 0.001
Charlson Index (points) (mean ± SD)
Fine I 0.63 ± 0.92 0.39 ± 0.72 < 0.01
Fine II 0.62 ± 0.51 0.70 ± 0.76 ns
Fine III 1.03 ± 1.03 0.99 ± 1.19 ns
Fine IV 1.54 ± 1.89 1.23 ± 1.35 ns
Fine V 0.67 ± 0.58 2.05 ± 2.08 < 0.01
DRG weight (points) (mean ± SD)
Fine I 0.97 ± 0.24 0.94 ± 0.24 ns
Fine II 0.88 ± 0.21 1.01 ± 0.43 ns
Fine III 0.95 ± 0.23 1.21 ± 1.13 ns
Fine IV 1.01 ± 0.18 1.11 ± 0.29 ns
Fine V 0.95 ± 0.15 1.16 ± 0.49 ns
Mortality [n (%)]
Fine I 0 0 ns
Fine II 0 0 ns
Fine III 0 2 (1.8%) ns
Fine IV 4 (5%) 6 (3.4%) ns
Fine V 1 (25%) 3 (8.1%) ns
SSU: short-stay unit; CH: conventional hospital unit; SD: standard
deviation, ns: not significant.
determinations performed, blood culture and serol-
ogy were, proportionally, the least useful in the di-
agnosis of CAP.
In regard to the total cost of hospital treat-
ment of patients with CAP28, it is well document-
ed that the reduction of mean stay greatly re-
duces the total cost. Fine et al. determined that
hospital room cost accounted for 59% of the to-
tal cost of hospital treatment of CAP, with a sav-
ing of $ 680 per day on a total of $ 5,94229. In a
Spanish study, Bartholomew et al. calculated the
cost of hospital treatment at € 1,553. By reduc-
ing inappropriate stays, costs could be reduced
by 8.1% with a total annual reduction of 17.4%2.
Thus treatment in SSU can reduce costs by re-
ducing mean stay time30.
This study has important limitations due to its
retrospective design. The decision to refer CAP pa-
tients to one or another unit is made by the emer-
gency department physician based on objective cri-
A. Juan et al.
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Table 4. Outcome of patients in risk group IV of the Pneumonia Severity Index (PSI)
SSU (N = 80) CH (N = 175) p value
General
Effectiveness
Average stay (days) (mean ± SD) 3.78 ± 1.77 9.09 ± 8.14 < 0.001
Destination at discharge [n (%)]
Home 63 (78.7) 157 (89.7) < 0.001
Home Hospitalization 3 (3.7) 11 (6.2)
Sub-acute Unit 11 (13.7) 1 (0.5)
Safety
Mortality [n (%)] 4 (5) 6 (3.4)
ED readmission within 10 days [n (%)] 1 (1.3) 6 (3.5) ns
Hospital readmission within 10 days [n (%)] 1 (1.3) 4 (2.3) ns
ED readmission within 30 days [n (%)] 2 (2.6) 17 (10.0) < 0.05
Hospital readmission within 30 days [n (%)] 2 (2.6) 11 (6.5) ns
By age group
Number of cases
40-49 years 0 (0) 6 (3.4) < 0.001
50-59 years 0 (0) 8 (4.5)
60-69 years 5 (6.2) 34 (19.4) 
70-79 years 18 (22.5) 66 (37.7)
80-89 years 36 (45.0) 56 (32.0)
 90 years 21 (26.2) 5 (2.8)
Effectiveness
Average stay (days)
60-69 years 4.00 ± 1.00 9.82 ± 6.31 < 0.001
70-79 years 3.22 ± 1.39 9.12 ± 6.45 < 0.001
80-89 years 4.19 ± 2.20 7.16 ± 4.18 < 0.001
 90 years 3.48 ± 1.16 9.20 ± 2.58 < 0.001
Safety
Mortality [n (%)]
60-69 years 0 (0) 1 (2.9) ns
70-79 years 1 (5.5) 2 (3.0)
80-89 years 1 (2.7) 3 (5.3)
 90 years 2 (9.5) 0 (0)
ED readmission within 10 days [n (%)]
60-69 years 0 (0) 1 (2.9) ns
70-79 years 1 (5.5) (6.0)
80-89 years 0 (0) (1.7)
 90 years 0 (0) 0 (0)
Hospital readmission within 10 days [n (%)]
60-69 years 0 (0) 1 (2.9) ns
70-79 years 1 (5.5) 3 (4.5)
80-89 years 0 (0) 0 (0)
 90 years 0 (0) 0 (0)
ED readmission within 30 days [n (%)]
60-69 years 0 (0) 3 (8.8) ns
70-79 years 1 (5.5) 8 (12.1)
80-89 years 1 (2.7) 5 (8.9)
 90 years 0 (0) 1 (20.0)
Hospital readmission within 30 days [n (%)]
60-69 years 0 (0) 2 (5.8) ns
70-79 years 1 (5.5) 5 (7.5)
80-89 years 1 (2.7) 3 (5.3)
 90 years 0 (0) 1 (20.0)
SSU: short-stay unit; CH: conventional hospital unit; SD: standard deviation; ED: emergency department.
teria, but above all, clinical judgement, and this
may result in selection bias. In order to minimize
this bias, our analysis excluded all patients requir-
ing intensive care on admission or during their stay.
This is the reason for the low mortality per PSI
group4, although no significant differences were
found between the groups. Although the general
recommendations for admission to our SSU tend to
exclude patients with social problems that make
early discharge impractical, in daily practice this is
often not possible. In fact, the selection of patients
is not especially favorable to the SSU, considering
the high proportion of patients with comorbidity
and from nursing homes, which are risk factors for
prolonged stay31. The difference between our study
groups could suggest that mean CH stay was ab-
normally long, but a review of the literature review
revealed a wide range of mean hospital stay in pa-
tients with CAP16-18,23,32-34. In any event, the CH
group allowed us to determine reference values on
mortality rate and return or readmission in our
study area and thus assess the acceptability of our
SSU results. Overall, it is reasonable to conclude
that, in our experience, properly selected CAP pa-
tients, including those with PSI IV, can be safely
and effectively treated with short hospital stay
regimes.
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Análisis de la seguridad y la eficacia de una unidad de corta estancia en el tratamiento
de la neumonía adquirida en la comunidad
Juan A, Jacob J, Llopis F, Gómez-Vaquero C, Ferré C, Ramón Pérez-Mas J, Palom X, Giol J, Ramón JM, Salazar A,
Corbella X
Introducción: La neumonía adquirida en la comunidad (NAC) es una patología de alta prevalencia que a menudo re-
quiere ingreso hospitalario. El objetivo de nuestro estudio es evaluar la eficacia y seguridad en el tratamiento de la
NAC de una unidad de corta estancia (UCE) como alternativa a las unidades de hospitalización convencional (UHC).
Método: Estudio retrospectivo comparativo de pacientes ingresados en un hospital terciario con diagnóstico al alta de
NAC entre noviembre del 2005 y abril del 2007. Se comparan dos grupos: pacientes ingresados en UCE frente a pa-
cientes ingresados en UHC (se excluyen pacientes que requieren terapia intensiva). Variables analizadas: edad y sexo,
índice de Charlson, peso según el grupo relacionado de diagnóstico (GRD), CURB 65 y Pneumonia Severity Index (PSI),
hallazgos microbiológicos, tasas de readmisión y de mortalidad.
Resultados: Un total de 606 pacientes fueron reclutados, 187 ingresados en el UCE (grupo 1) y 419 en UHC (grupo 2
o grupo control). Las diferencias más significativas entre los dos grupos fueron el promedio de edad (77,3 vs 67,9
p < 0,001) y la estancia promedio (3,48 vs 7,89 p < 0,001). Estas diferencias se objetivan en el comparativo general y
por subgrupos según la escala de riesgo (PSI). No se observaron diferencias significativas en la tasa de mortalidad ni en
la de reingreso entre las dos formas de hospitalización.
Conclusiones: La UCE es eficaz y segura en el manejo de los pacientes con NAC, con una estancia media significativamen-
te inferior respecto a las UHC, y sin diferencias en las tasas de mortalidad y reingreso. [Emergencias 2011;23:175-182]
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